Imagine if Tony Stark created an AI to help approve your meds—pretty wild, right? Well, this isn’t quite Iron Man status, but the FDA is taking a serious coffee break with OpenAI to discuss a little something they’re calling cderGPT. Sounds fancy, doesn’t it?
In the latest buzz, FDA Commissioner Marty Makary dreamt up a plan to turbocharge the drug approval process using AI. Because let’s face it, waiting for life-saving meds is so 20th century. With AI-powered tools, they hope to shave off some time, making pharmaceuticals available faster than you can say ‘Where’s my prescription?’
While we’re all for quicker approvals, one might wonder—is it a leap forward, or just tech jumping the gun? In a world where machines sometimes can’t find the difference between a cat and a hotdog, will AI really know how to evaluate drugs without having a mental meltdown?
Whatever happens, it’s clear that AI is eyeing a seat at the FDA’s table, and let’s hope it remembers to play nice with the humans! What are your thoughts? Are we ready to let the robots in on our health?
Leave a Reply